all the information, none of the junk | biotech • healthcare • life sciences

Bluebird Names COO, Taps Shire Exec To Lead Euro Ops

Xconomy Boston — 

Cambridge, MA-based Bluebird Bio (NASDAQ: BLUE) has named Susanna High, formerly of Alnylam Pharmaceuticals and Millennium Pharmaceuticals, its chief operating officer. Andrew Obenshain, a veteran of Shire and Genzyme before that, will lead Bluebird’s operations in Europe.